The propranolol paradox: how beta-blockers treat and sustain your migraine at the same time

Propranolol is one of the most commonly prescribed medications for migraine prevention. Millions of people around the world take it every day. It is on the WHO Essential Medicines List, and most neurologists recommend it as a first-line treatment.

But there is a fundamental contradiction in this prescribing practice. Propranolol suppresses melatonin production by 80 to 86%, and melatonin is precisely the substance that protects against migraine.

Fact 1: melatonin protects against migraine

Everyone knows melatonin as the sleep hormone, but it does much more than that. It is a powerful antioxidant, an anti-inflammatory and a regulator of your circadian rhythm. And it plays a direct role in migraine:

• People with migraine have significantly lower melatonin levels than healthy controls [1].
• A maintenance dose of 3 mg melatonin reduces migraine by 2.7 days per month, comparable to amitriptyline 25 mg, a recognised migraine preventive [2].
• The most recent meta-analysis (2026, 9 RCTs, 788 patients) confirms it: significantly fewer attacks, shorter duration and better sleep quality [3].

So melatonin is not a side issue. It is an active player in your protection against migraine.

Fact 2: propranolol wipes out melatonin

Propranolol is a non-selective beta-blocker. It blocks beta-adrenergic receptors, not only in your heart and blood vessels, but also on the pinealocytes in your pineal gland, the organ that makes melatonin.

The mechanism is clear. At night, your sympathetic nervous system releases noradrenaline. Through beta-adrenergic receptors on the pineal gland, that noradrenaline stimulates the enzyme AANAT, the rate-limiting enzyme in melatonin synthesis. Propranolol blocks exactly this signal [4, 5].

• 80-86% reduction in night-time melatonin [6]
• Insomnia and poorer sleep quality
• Nightmares and vivid dreams
• A disrupted biological rhythm

Sleep disruption is one of the strongest migraine triggers there is [7]. But it goes further than sleep alone: a disrupted biological rhythm also throws your immune system off balance. As a result, your body loses its ability to keep the neuroinflammation that comes with migraine under control.

The paradox

Propranolol treats your migraine with one hand, while the other hand dismantles your natural protection.

On top of that, propranolol is less effective than is often assumed. Meta-analyses show a reduction of only 1.3 attacks per month compared with placebo [11]. Of every 6 to 7 patients who take it, only one actually benefits beyond what a placebo would do. A 2010 BMJ study even found that propranolol as monotherapy performed no significantly better than optimised acute care alone [12].

Add the melatonin suppression to that, and the picture becomes even sharper: the modest effect of propranolol is partly undermined by its own side effect.

Practice proves it

In 2024, Mehramiri et al. published a double-blind, placebo-controlled RCT with 60 migraine patients. All patients received propranolol (standard care). Half of them also received 3 mg melatonin, the other half a placebo [8].

Adding melatonin to propranolol significantly improved almost every outcome:

• Attack frequency: significantly lower
• Attack duration: significantly shorter
• Painkiller use: fewer analgesics needed
• MIDAS score: fewer limitations in daily functioning
• Sleep quality (PSQI): significantly better

Side effects were minimal and comparable to placebo.

In other words: once the suppressed melatonin is replenished, the artificial ceiling disappears and every outcome improves. The researchers conclude that supplementing melatonin can strengthen the effect of propranolol.

But can you combine melatonin with beta-blockers?

Many melatonin products carry a warning: “Do not use with blood pressure-lowering medication.” That is off-putting. But what is that warning based on?

The reasoning is theoretical. Slow-release melatonin lowers night-time blood pressure by an average of 6 mmHg [9]. Blood pressure medication does the same. Hence a theoretical risk of blood pressure dropping too low.

But the evidence says something different:

• The RCT by Scheer et al. (2012) specifically combined melatonin with beta-blockers. The result: no blood pressure problems, no tolerance, no rebound insomnia, and significantly better sleep [10].
• There are zero published case reports of dangerous hypotension with the combination of melatonin and a beta-blocker.
• The EMA product information for Circadin (registered melatonin) lists hypertension as a rare side effect, not hypotension.
• The blood pressure effect only applies to slow-release melatonin, not to fast-release forms such as sprays (-0.3 mmHg, not significant) [9].

The available evidence, including an RCT that tested this exact combination, shows no safety problems. The warning on melatonin products is based on a theoretical risk, not on clinical findings.

The cPNI perspective

From the perspective of clinical Psycho-Neuro-Immunology (cPNI), the propranolol paradox is a textbook example of what goes wrong when linear pharmacological thinking is applied to a non-linear system.

Your body is not a machine with isolated levers. It is a network of interdependent systems. When you pull one lever, others move with it, sometimes in the wrong direction.

Propranolol targets one pathway (vascular tone and neuronal stabilisation), but at the same time it disrupts other crucial systems: your circadian rhythm, your sleep, your pineal function. And through that disrupted sleep it indirectly affects your immune system, your stress axis and your energy balance as well.

That is exactly what we see again and again in chronic migraine: layered disruptions that reinforce one another. A medication that addresses one layer but disrupts another does not solve the problem at its root.

What does this mean for you?

Some people do benefit from propranolol. The figures show that roughly 1 in 6 to 7 patients gets a measurable benefit beyond placebo [11]. But for the majority the effect remains limited, while the melatonin suppression affects everyone who takes it.

Have you been struggling with insomnia, nightmares or restless sleep since starting beta-blockers? That may come directly from the melatonin suppression. And that disrupted sleep can in turn keep your migraine going.

Never stop medication on your own without talking to your doctor. This article is for information only and does not replace medical advice.

Conclusion

The propranolol paradox shows why migraine cannot be solved with a single pill. Your body is a network. Effective migraine treatment calls for systems thinking: not only which symptom you suppress, but also what consequences that suppression has elsewhere.

Want to understand what drives your migraine and which systems are out of balance in your case? Start with the Building Block Analysis.

References

1. Liampas I, Siokas V, Brotis A, Vikelis M, Dardiotis E. Endogenous Melatonin Levels and Therapeutic Use of Exogenous Melatonin in Migraine: Systematic Review and Meta-Analysis. Headache. 2020;60(7):1273-1299. PMID: 32352572.
2. Gonçalves AL, Martini Ferreira A, Ribeiro RT, Zukerman E, Cipolla-Neto J, Peres MF. Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention. J Neurol Neurosurg Psychiatry. 2016;87(10):1127-1132. PMID: 27165014.
3. Abouelmagd ME, et al. Efficacy and Safety of Melatonin in Migraine Prophylaxis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Curr Pain Headache Rep. 2026;30(1):25. PMID: 41627537.
4. Arendt J. Melatonin: Countering Chaotic Time Cues. Front Endocrinol. 2019;10:391.
5. Zisapel N. New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. Br J Pharmacol. 2018;175(16):3190-3199.
6. Stoschitzky K, Sakotnik A, Lercher P, et al. Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol. 1999;55(2):111-115. PMID: 10335905.
7. Kelman L, Rains JC. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache. 2005;45(7):904-910.
8. Mehramiri A, Shalilahmadi D, Mohamadianinejad SE, Kouti L, Hosseinpour Y. The Effect of Melatonin on Reducing the Frequency and Severity of Migraine Attacks: A Double-Blind, Randomized Clinical Trial. Iran J Med Sci. 2024;49(5):313-321. doi:10.30476/ijms.2023.97782.2965.
9. Grossman E, Laudon M, Zisapel N. Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials. Vasc Health Risk Manag. 2011;7:577-584.
10. Scheer FA, Morris CJ, Garcia JI, et al. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial. Sleep. 2012;35(10):1395-1402. PMID: 23024438.
11. Jackson JL, Cogbill E, Santana-Davila R, et al. A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache. PLOS ONE. 2015;10(7):e0130733. PMID: 26172390.
12. Holroyd KA, Cottrell CK, O’Donnell FJ, et al. Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine. BMJ. 2010;341:c4871. PMID: 20880898.